<i>In vitro</i> evaluation of the interaction between orbital fibroblasts and PBMCs from Graves' orbitopathy patients in triggering periorbital remodeling. [PDF]
Front ImmunolStarosz A +6 more
europepmc +1 more source
Graves’ Orbitopathy and Oxidative Stress [PDF]
Orbit, 2010 C. Novembrino +4 more
openaire +3 more sources
Complications after radiotherapy in patients with Graves' orbitopathy: A nationwide cohort study. [PDF]
Eye (Lond)Lee J, Ahn HY, Heo JS, Kim M, Lee JK.
europepmc +1 more source
Selenium Supplementation in Graves' Orbitopathy: Effects on Blood Concentrations and Clinical Outcomes. [PDF]
Clin OphthalmolLumyongsatien M +5 more
europepmc +1 more source
Unravelling the pathogenic mechanisms in Graves' orbitopathy. [PDF]
Eur Thyroid JLee ACH, Kahaly GJ.
europepmc +1 more source
Dysthyroid Optic Neuropathy in Graves' Orbitopathy: Insights from a Single Centre and Limitations of the Radiological Indices. [PDF]
Indian J Endocrinol MetabAgarwal K +12 more
europepmc +1 more source
Efficacy and safety of secondary infero-medial orbital wall decompression after orbital fat decompression in Graves' orbitopathy: A 12-year experience. [PDF]
Indian J OphthalmolCheng AMS +6 more
europepmc +1 more source
Sarilumab in the management of Graves orbitopathy with low clinical activity scores. [PDF]
Sci RepPérez-Moreiras J +3 more
europepmc +1 more source
Correction: Role of the suppressor of cytokine signaling-3 in the pathogenesis of Graves' orbitopathy. [PDF]
Front Endocrinol (Lausanne)Kim W +7 more
europepmc +1 more source
The impact of graves' orbitopathy on anterior segment structures and choroidal parameters. [PDF]
BMC OphthalmolSevimli N +3 more
europepmc +1 more source